At Versa Biomedical we use preclinical models that deliver reliable, reproducible results directly applicable to clinical practice. Among them, the porcine model plays a central role due to its remarkable anatomical, physiological, and cardiovascular similarity to humans, which makes it a widely accepted standard in biomedical research.
The use of pigs in preclinical studies has grown strongly over the past decades. Scientific publications employing porcine models in biomedical research have increased eightfold in the last thirty years, reflecting their rising relevance in fields such as cardiovascular surgery, oncology, and gene therapies. Today, pigs account for approximately 20–25% of the large animals used in preclinical testing, underlining their importance when validating efficacy and safety before advancing to clinical trials.
Alongside the porcine model, Versa also works with human cadavers, providing a complementary framework that ensures scientific rigor and the closest possible approximation to real clinical practice.